Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Octreotide acetate | Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone , glucagon , and insulin more potently. Uses: Scientific research. Group: Peptides. Alternative Names: SMS 201-995 acetate. CAS No. 79517-01-4. Pack Sizes: 5 mg; 10 mg; 50 mg. Product ID: HY-17365. |  |
| Octreotide Acetate | Octreotide Acetate. Categories: octreotide acetate; sandostatin lar. |  CA, FL & NJ |
| Octreotide Acetate | Octreotide acetate is a long-acting octapeptide with pharmacologic actions similars to the natural hormone somatostatin. It is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was approved as an injectable depot formulation used for acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors. It is a gastric antisecretory agent andcould inhibit the secretion of insulin and glucagon. It reduces production of IGF-1 and IGF-2 by the liver by modulation of growth-hormone secretion from the pituitary gland. It decreased the urinary excretion of uric acid as well as the plasma concentrations of glucagon and insulin. It decreased the urinary excretion of sodium and chloride without significiant influence on creatinine clearance, while the concentrations of lactic acid, pyruvic acid in blood, and cyclic AMP in plasma were not changed. It was first synthesized in 1979 by the chemist Wilfried Bauer and was developed by Novartis Pharmaceuticals. Uses: Antineoplastic agents, hormonal. Synonyms: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, acetate (1:x); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol.xCH3CO2H (Disulfide Bridge between Cys2-Cys7); D-phenÂ… |  |
| Octreotide Acetate | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsbuilding blocks. Alternative Names: Octreotide acetate, Sandostatin LAR, SMS 201-995ac, Sandostatin, L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, [R-(R*,R*)]-, acetate (salt),L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, acetate (1:?), 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv., Octreotide LAR, L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, acetate (salt) (9CI). |  |
| Octreotide acetate impurity F | Octreotide acetate impurity F. Uses: For analytical and research use. Group: Impurity standards. CAS No. 133304-81-1. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. Catalog: APB133304811. | |
| Octreotide Acetate (SMS 201995, Sandostatin) | Octapeptide analog of Somatostatin. A gastric antisecretory agent. Used in treatment of acromegaly. Group: Biochemicals. Alternative Names: SMS 201995; Sandostatin; D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-Alcohol; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-7)-disulfide acetate. Grades: Highly Purified. CAS No. 79517-01-4. Pack Sizes: 1mg, 5mg, 10mg. Molecular Formula: C49H66N10O10S2, Molecular Weight: 1019.24. US Biological Life Sciences. |  Worldwide |
| 13C6-Lys Octreotide Trifluoroacetate | 13C6-Lys Octreotide Trifluoroacetate, is labelled Octreotide (O239950, acetate salt) which is an analog of Somatostatin (S676750, acetate salt). Octreotide (O239950, acetate salt) is a gastric antisecretory agent and it is used in treatment of acromegaly. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 5mg. Molecular Formula: C4313C6H66N10O10S2; xC2HF3O2. US Biological Life Sciences. | Worldwide |
| Acetyl-Lys5-octreotide Acetate | Acetyl-Lys5-octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: Lys(Ac)-Octreotide Acetate; D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl(acetyl)-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7). Grade: 98%. Molecular formula: C51H68N10O11S2.xC2H4O2. Mole weight: 1061.28 (free base). | |
| Acetyl-Phe1-octreotide Acetate | Acetyl-Phe1-octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanylD-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI); Ac-D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide Acetate. Grade: 98%. CAS No. 83795-62-4. Molecular formula: C51H68N10O11S2.xC2H4O2. Mole weight: 1061.28 (free base). | |
| Acetyl-(Phe1)-Octreotide trifluoroacetate salt | Acetyl-(Phe1)-Octreotide trifluoroacetate salt is an impurity of octreotide. Synonyms: Ac-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol trifluoroacetate salt (Disulfide bridge: Cys2-Cys7). Molecular formula: C51H68N10O11S2.C2HF3O2. Mole weight: 1175.30. | |
| D-Thr(6)-Octreotide Acetate | D-Thr(6)-0ctreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-,cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI). Grade: 95%. CAS No. 87759-90-8. Molecular formula: C49H66N10O10S2.xC2H4O2. | |
| (Cysteinol7,des-L-threoninol8)-Octreotide | (Cysteinol7,des-L-threoninol8)-Octreotide is an impuritiy of octreotide. Synonyms: H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-cysteinol (Disulfide bridge: Cys2-Cys7); Octreotide Impurity 8; Octreotide Acetate Impurity 11. Grade: ≥95%. CAS No. 1546983-18-9. Molecular formula: C45H59N9O8S2. Mole weight: 918.14. | |
| DOTATATE acetate | DOTATATE acetate is a radiolabeled somatostatin analog used in medical imaging and therapy for neuroendocrine tumors (NETs). DOTATATE acetate is a peptide derivative that binds selectively to somatostatin receptors (mainly subtype 2), which are overexpressed on the surface of neuroendocrine tumor cells. This allows for specific targeting of these tumors. Synonyms: L-Threonine, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, acetate (salt) (1:x); DOTA-(Tyr3,Thr8)-Octreotide acetate; DOTA-[Tyr3] Octreotide Acid (Octreotate) acetate; DOTA-octreotate acetate; DOTA-[Tyr3]-Octreotide Acid acetate. Grade: 98%. CAS No. 177943-89-4. Molecular formula: C65H90N14O19S2.xC2H4O2. Mole weight: 1435.63 (free base). | |
| [Tyr3,Lys5(Boc)]Octreotide | An impurity of Octreotide. Octreotide is a synthetic long-acting cyclic octapeptide that inhibits growth hormone, glucagon and insulin more effectively than somatostatin. Synonyms: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; H-D-Phe-Cys-Tyr-D-Trp-Lys(Boc)-Thr-Cys-Thr-ol,cyclic disulfide; H-D-Phe-Cys(1)-Tyr-D-Trp-Lys(Boc)-Thr-Cys(1)-Thr-ol; D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-N6-tert-butoxycarbonyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide; [Tyr3,Lys5(Boc)]Octreotide acetate. Grade: ≥95%. CAS No. 147790-89-4. Molecular formula: C54H74N10O13S2. Mole weight: 1135.36. | |
| [Ac-D-Phe1,D-Cys7]-Octreotide | An impurity of Octreotide. Octreotide is a synthetic long-acting cyclic octapeptide that inhibits growth hormone, glucagon and insulin more effectively than somatostatin. Synonyms: Ac-DPhe-Cys-Phe-DTrp-Lys-Thr-DCys-Thr-ol(Cys2&Cys7 bridge); Ac-DPhe-CF-DTrp-KT-DCys-Thr-ol(Cys2&Cys7 bridge); Ac-D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-D-cysteinamide cyclic (2→7)-disulfide; [D-Phe1(Ac),D-Cys7]-Octreotide; Ac-D-Phe-Cys-Phe-D-Trp-Lys-Thr-D-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7). Grade: ≥95%. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. | |
| Ac-Octreotide | Ac-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: Ac-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol(Cys2&Cys7 bridge); N2.1-Acetyloctreotide; Ac-D-Phe-c(Cys-Phe-D-Trp-Lys-Thr-Cys)-Thr-ol; Octreotide EP Impurity I; Ac-D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide; L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfide; D-Phe(Ac)-Octreotide; Ac-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7); Acetyl-Octreotide; Acetyl-Phe1-octreotide; N-Acetyl-D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2→7)-disulfide. Grade: ≥95%. CAS No. 83795-61-3. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. | |
| DOTA-NOC | DOTA-NOC is a potent chelating agent extensively used in radiopharmaceuticals for the targeted imaging and therapy of neuroendocrine tumors. By combining with diverse radiometals, such as lutetium-177 or yttrium-90, it generates therapeutic agents that specifically bind to neuroendocrine tumor cells. The DOTA-NOC derivatives have displayed remarkable specificity and affinity for somatostatin receptors, endowing it with a unique potential for cancer therapy. Its diverse applications stem from its impressive properties, which include high burstiness in sentence structure and an elevated level of perplexity in its descriptions. Synonyms: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; DOTA-[Nal3]-octreotide; H-D-Phe(DOTA)-Cys(1)-Nal-D-Trp-Lys-Thr-Cys(1)-Thr-ol; DOTA-D-Phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide. Grade: 95%. CAS No. 619300-53-7. Molecular formula: C69H94N14O17S2. Mole weight: 1455.70. | |
| DOTATATE | DOTATATE is a radiolabeled somatostatin analog used in medical imaging and therapy for neuroendocrine tumors (NETs). DOTATATE is a peptide derivative that binds selectively to somatostatin receptors (mainly subtype 2), which are overexpressed on the surface of neuroendocrine tumor cells. This allows for specific targeting of these tumors. Synonyms: L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide; L-Threonine, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide; DOTA-octreotate; DOTA-TATE; DOTA-[Tyr3]-Octreotide Acid; DOTA-(Tyr3)-octreotate. Grade: ≥95%. CAS No. 177943-88-3. Molecular formula: C65H90N14O19S2. Mole weight: 1435.63. | |
| Edotreotide | Edotreotide is a substance used in the treatment and diagnosis of certain types of cancer. Synonyms: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; (DOTA-D-Phe1,Tyr3)octreotide; DOTATOC; SDZ-SMT 487; SMT 487; SomaKit TOC; DOTA-(Tyr3)-Octreotide; SMT-487; SMT487; DOTA-d-Phe1-Tyr3-octreotide; DOTA-TOC. Grade: 98%. CAS No. 204318-14-9. Molecular formula: C65H92N14O18S2. Mole weight: 1421.64. | |
| L-Threoninol(Ac)-8-Octreotide | L-Threoninol(Ac)-8-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol-Ac(Cys2&Cys7 bridge); DPhe-CF-DTrp-KTC-Thr-ol-Ac(Cys2&Cys7 bridge); O1.8-Acetyloctreotide; Octreotide EP Impurity F; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L(Acetyl)-threoninol (Disulfide Bridge between Cys2-Cys7); Octreotide Impurity F; H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Ac-Thr-ol (Disulfide bridge: Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; O-Acetyl Octreotide; [O1(AC)]8-Octreotide; (L-Threoninol(Ac)8)-Octreotide. Grade: ≥95%. CAS No. 133304-81-1. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. | |
| Lys(Ac)-Octreotide | Lys(Ac)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Uses: Radiopharmaceuticals. Synonyms: DPhe-Cys-Phe-DTrp-Lys(Ac)-Thr-Cys-Thr-ol(Cys2&Cys7 bridge); N6.5-Acetyloctreotide; D-Phe-c(Cys-Phe-D-Trp-Lys(Ac)-Thr-Cys)-Thr-ol; Lys(Ac) 5 Octreotide; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl(acetyl)-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; Octreotide EP Impurity H; Octreotide Impurity H; Acetyl-Lys5-octreotide; D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-(N-acetyl)-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2→7)-disulfide. Grade: ≥95%. CAS No. 173606-11-6. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. | |
Our database is helping our users find suppliers everyday.
